ArticlePloS one2024

Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardio-cerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic patients.

Eiji Nakatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.